Business Context and Reporting Period
This Form 8-K is a current report filed by Synaptogenix, Inc. (not TAO Synergies Inc.) on October 4, 2024, covering events occurring on September 30, 2024. The registrant is an emerging growth company incorporated in Delaware, with its principal executive offices in New York, New York. The filing primarily addresses a change in the company's independent registered public accounting firm.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on the administrative change of the external auditor.
Material Changes
- Resignation of Auditor: Morison Cogen LLP resigned as the independent registered public accounting firm on September 30, 2024. The resignation coincides with Morison Cogen's exit from providing audit services to publicly traded companies.
- Engagement of New Auditor: On October 4, 2024, the company engaged Stephano Slack LLC as its new independent registered public accounting firm for the fiscal year ending December 31, 2024.
- Audit History: Morison Cogen's reports for the fiscal years ended December 31, 2023, and 2022, did not contain adverse opinions, disclaimers, or qualifications regarding uncertainty, audit scope, or accounting principles.
Guidance, Outlook, and Risks
The filing states there were no disagreements between the company and Morison Cogen regarding accounting principles, financial statement disclosure, or auditing scope during the relevant periods. Additionally, no reportable events occurred under Item 304(a)(1)(v) of Regulation S-K. The company has not consulted with the new auditor, Stephano Slack, on any accounting or auditing matters prior to their engagement. No forward-looking guidance or specific risk factors beyond the standard auditor transition are disclosed in this document.
Investor Verification Checklist
- Verify the transition timeline between Morison Cogen LLP and Stephano Slack LLC to ensure no gap in audit coverage.
- Review the letter from Morison Cogen LLP (Exhibit 16.1) to confirm their agreement with the company's disclosures regarding the resignation.
- Monitor upcoming filings (e.g., 10-Q or 10-K) to assess the new auditor's initial findings and any potential restatements.
- Confirm the company's status as an emerging growth company and its implications for financial reporting standards.